HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Efficacy of combined treatments comprising 6 months' administration of rifampicin in multibacillary leprosy].

Abstract
Ten patients infected with mouse proven DDS-resistant bacilli were treated with the following combined regimen: RMP 600 2/7 6 months, ETH 500 7/7 6 months and DDS 100 7/7 12 months. Follow up was for 27-54 months, without relapses. Added to patients from previous study (Int. J. Lepr. 1984, 52, 297-303) the 95% confidence limit decreases from 12 to 9%.
AuthorsS R Pattyn, J A Husser, P Saint-André
JournalActa leprologica (Acta Leprol) 1986 Oct-Dec Vol. 4 Issue 4 Pg. 445-6 ISSN: 0001-5938 [Print] Switzerland
Vernacular TitleEfficacité de traitements combinés comportant six mois d'administration de rifampicine dans la lèpre multibacillaire.
PMID3296614 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Dapsone
  • Ethionamide
  • Rifampin
Topics
  • Dapsone (therapeutic use)
  • Drug Therapy, Combination
  • Ethionamide (therapeutic use)
  • Humans
  • Leprosy (drug therapy)
  • Rifampin (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: